159 related articles for article (PubMed ID: 38092886)
1. An adjunct microbiome therapy to enhance immunotherapy efficacy in melanoma patients.
Lenehan JG; Maleki Vareki S
Genes Immun; 2024 Feb; 25(1):87-88. PubMed ID: 38092886
[No Abstract] [Full Text] [Related]
2. Role of gut microbiome on immunotherapy efficacy in melanoma.
Bibbò S; Ianiro G; Giambò F; Settanni CR; Cammarota G; Gasbarrini A
Hum Vaccin Immunother; 2022 May; 18(3):1926759. PubMed ID: 34190675
[TBL] [Abstract][Full Text] [Related]
3. The gut microbiome and melanoma: A review.
Makaranka S; Scutt F; Frixou M; Wensley KE; Sharma R; Greenhowe J
Exp Dermatol; 2022 Sep; 31(9):1292-1301. PubMed ID: 35793428
[TBL] [Abstract][Full Text] [Related]
4. Role of the Microbiome in Immunotherapy of Melanoma.
Jiminez V; Yusuf N
Cancer J; 2023 Mar-Apr 01; 29(2):70-74. PubMed ID: 36957976
[TBL] [Abstract][Full Text] [Related]
5. The cure from within? a review of the microbiome and diet in melanoma.
Kumar P; Brazel D; DeRogatis J; Valerin JBG; Whiteson K; Chow WA; Tinoco R; Moyers JT
Cancer Metastasis Rev; 2022 Jun; 41(2):261-280. PubMed ID: 35474500
[TBL] [Abstract][Full Text] [Related]
6. Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients.
Peters BA; Wilson M; Moran U; Pavlick A; Izsak A; Wechter T; Weber JS; Osman I; Ahn J
Genome Med; 2019 Oct; 11(1):61. PubMed ID: 31597568
[TBL] [Abstract][Full Text] [Related]
7. DeepGeni: deep generalized interpretable autoencoder elucidates gut microbiota for better cancer immunotherapy.
Oh M; Zhang L
Sci Rep; 2023 Mar; 13(1):4599. PubMed ID: 36944780
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers.
McQuade JL; Ologun GO; Arora R; Wargo JA
Curr Oncol Rep; 2020 Jun; 22(7):74. PubMed ID: 32577835
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.
Gopalakrishnan V; Spencer CN; Nezi L; Reuben A; Andrews MC; Karpinets TV; Prieto PA; Vicente D; Hoffman K; Wei SC; Cogdill AP; Zhao L; Hudgens CW; Hutchinson DS; Manzo T; Petaccia de Macedo M; Cotechini T; Kumar T; Chen WS; Reddy SM; Szczepaniak Sloane R; Galloway-Pena J; Jiang H; Chen PL; Shpall EJ; Rezvani K; Alousi AM; Chemaly RF; Shelburne S; Vence LM; Okhuysen PC; Jensen VB; Swennes AG; McAllister F; Marcelo Riquelme Sanchez E; Zhang Y; Le Chatelier E; Zitvogel L; Pons N; Austin-Breneman JL; Haydu LE; Burton EM; Gardner JM; Sirmans E; Hu J; Lazar AJ; Tsujikawa T; Diab A; Tawbi H; Glitza IC; Hwu WJ; Patel SP; Woodman SE; Amaria RN; Davies MA; Gershenwald JE; Hwu P; Lee JE; Zhang J; Coussens LM; Cooper ZA; Futreal PA; Daniel CR; Ajami NJ; Petrosino JF; Tetzlaff MT; Sharma P; Allison JP; Jenq RR; Wargo JA
Science; 2018 Jan; 359(6371):97-103. PubMed ID: 29097493
[TBL] [Abstract][Full Text] [Related]
10. The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients.
Natarelli N; Aflatooni S; Boby A; Krenitsky A; Grichnik J
J Drugs Dermatol; 2024 Feb; 23(2):78-84. PubMed ID: 38306142
[TBL] [Abstract][Full Text] [Related]
11. Microbiome analysis combined with targeted metabolomics reveal immunological anti-tumor activity of icariside I in a melanoma mouse model.
Chen G; Cao Z; Shi Z; Lei H; Chen C; Yuan P; Wu F; Liu C; Dong M; Song Y; Zhou J; Lu Y; Zhang L
Biomed Pharmacother; 2021 Aug; 140():111542. PubMed ID: 34088571
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma.
Limeta A; Ji B; Levin M; Gatto F; Nielsen J
JCI Insight; 2020 Dec; 5(23):. PubMed ID: 33268597
[TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.
Baruch EN; Youngster I; Ben-Betzalel G; Ortenberg R; Lahat A; Katz L; Adler K; Dick-Necula D; Raskin S; Bloch N; Rotin D; Anafi L; Avivi C; Melnichenko J; Steinberg-Silman Y; Mamtani R; Harati H; Asher N; Shapira-Frommer R; Brosh-Nissimov T; Eshet Y; Ben-Simon S; Ziv O; Khan MAW; Amit M; Ajami NJ; Barshack I; Schachter J; Wargo JA; Koren O; Markel G; Boursi B
Science; 2021 Feb; 371(6529):602-609. PubMed ID: 33303685
[TBL] [Abstract][Full Text] [Related]
14. Microbiome modulates immunotherapy response in cutaneous squamous cell carcinoma.
Voigt AY; Walter A; Young TH; Graham JP; Batista Bittencourt BM; de Mingo Pulido A; Prieto K; Tsai KY; Sundberg JP; Oh J
Exp Dermatol; 2023 Oct; 32(10):1624-1632. PubMed ID: 37350109
[TBL] [Abstract][Full Text] [Related]
15. Fecal microbiota transplants may aid melanoma immunotherapy resistance.
Fillon M
CA Cancer J Clin; 2021 Jul; 71(4):285-286. PubMed ID: 34101828
[No Abstract] [Full Text] [Related]
16. Microbiome: Gut microbiota sways response to cancer immunotherapy.
York A
Nat Rev Microbiol; 2018 Mar; 16(3):121. PubMed ID: 29355853
[No Abstract] [Full Text] [Related]
17. Consistent Stool Metagenomic Biomarkers Associated with the Response To Melanoma Immunotherapy.
Olekhnovich EI; Ivanov AB; Babkina AA; Sokolov AA; Ulyantsev VI; Fedorov DE; Ilina EN
mSystems; 2023 Apr; 8(2):e0102322. PubMed ID: 36809182
[TBL] [Abstract][Full Text] [Related]
18. Cross communication of diet-microbiome-immune interactions in cancer immunotherapy.
Zhou CB; Fang JY
Cell Rep Med; 2022 Nov; 3(11):100806. PubMed ID: 36384089
[TBL] [Abstract][Full Text] [Related]
19. Diosgenin promotes antitumor immunity and PD-1 antibody efficacy against melanoma by regulating intestinal microbiota.
Dong M; Meng Z; Kuerban K; Qi F; Liu J; Wei Y; Wang Q; Jiang S; Feng M; Ye L
Cell Death Dis; 2018 Oct; 9(10):1039. PubMed ID: 30305604
[TBL] [Abstract][Full Text] [Related]
20. [Intestinal microbiota affects immunotherapy in melanoma patients].
Schmutz JL
Ann Dermatol Venereol; 2016 Oct; 143(10):669-670. PubMed ID: 27546223
[No Abstract] [Full Text] [Related]
[Next] [New Search]
